Delivery Order SPE2DB22D3016-SPE2DB24FAML9
Award Date 2/15/24
Potential Completion Date 2/16/24
Potential Value $5.3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $3,914.52 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 and in effect through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to provide a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,093.99 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 10 mg pharmaceutical kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract, valued at $2,648.30, to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 20 mg kits. This delivery order is placed under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $12,017.02 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 30 mg kits. This delivery order falls under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00, for the supply of pharmaceutical products and medical supplies to DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $6,562.82 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, to provide Sandostatin LAR Depot 30 mg kits. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,389,740 units of Sandostatin LAR Depot 20 mg pharmaceutical kits. The $9,741.90 firm fixed price contract has an ultimate completion date of April 25, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $3,399.59 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) for the supply of Sandostatin LAR Depot 10 mg kits. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,631.34 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of Sandostatin LAR Depot 10 mg kits. This delivery order contract has an ultimate completion date of April 3, 2024 and was awarded on April 2, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC)...
- The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Sandostatin LAR Depot 30 mg kits. The contract, valued at $3,914.52, has an ultimate completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the parent company Cencora, Inc. doing business as Amerisourcebergen is also mentioned. This award is part of an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,648.30 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is for the delivery of Sandostatin LAR Depot, a specialty pharmaceutical product, with a completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAML9Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,296.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Sandostatin LAR Depot 20 mg kits. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Generated 5/16/24, 10:00 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 2/15/24 |